Testagen

Testagen (Lys-Glu-Asp-Gly, KEDG) is a synthetic tetrapeptide bioregulator developed from extracts of the anterior lobe of the pituitary gland. Its amino acid composition specifically reflects the peptide content of anterior pituitary tissue, making it part of the organ-specific bioregulator approach pioneered by Professor Vladimir Khavinson's research group. Unlike Triptorelin or Gonadorelin - which act directly on GnRH receptors to stimulate or suppress gonadotropin release - Testagen is proposed to act at the cellular level within the pituitary itself, supporting the health and differentiation of gonadotroph cells that produce LH and FSH.

The anterior pituitary is the master endocrine gland: it receives hypothalamic signals (including GnRH) and translates them into gonadotropin production. Age-related decline in pituitary gonadotroph function contributes to the progressive fall in testosterone that characterises male aging. While much attention focuses on testicular Leydig cell dysfunction as the primary cause of age-related testosterone decline, pituitary gonadotroph aging also contributes to the picture - impairing the LH pulses that stimulate Leydig cells.

Research into Testagen has shown encouraging results in models of chronic inflammation-associated testosterone reduction. In these studies, Testagen was associated with improved uroflowmetric parameters (relevant to prostate function), reduced prostate inflammation markers, and an increase in total testosterone levels. The researchers described "a decrease in the level of inflammation in the prostate, an increase in the level of total testosterone" - suggesting a combined anti-inflammatory and testosterone-supportive profile.

The proposed molecular mechanism involves Testagen's interaction with histones, particularly N-terminal histone regions. Short peptides that interact with histone proteins can influence chromatin structure, affecting which genes are accessible for transcription. In pituitary gonadotroph cells, this could translate to altered expression of gonadotropin genes (LH-beta, FSH-beta subunits) and their regulatory factors, potentially restoring age-diminished gonadotropin synthesis capacity.

Testagen is positioned within the Khavinson bioregulator system as the component targeting reproductive endocrine function, complementing Epitalon (pineal/neuroendocrine) and Thymalin (immune). For comprehensive testosterone support research, it is sometimes combined with Epitalon and Cardiogen in longevity protocols.